LigaChem Biosciences Inc. — Investor Relations & Filings
LigaChem Biosciences Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of innovative medicines. Leveraging its core expertise in medicinal chemistry, the company focuses on developing Antibody-Drug Conjugates (ADCs), immuno-oncology drugs, and small molecules. A key asset is its proprietary, next-generation ADC platform technology, engineered to overcome the limitations of conventional ADC technologies. The company's pipeline includes multiple programs targeting oncology, as well as other therapeutic areas such as antibiotics and anti-fibrotics. LigaChem Biosciences actively pursues global drug development through strategic partnerships, including co-development and licensing agreements with international pharmaceutical companies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]주요사항보고서(무상증자결정) | 2020-06-09 | Korean | |
| [기재정정]주요사항보고서(무상증자결정) | 2020-06-05 | Korean | |
| [기재정정]주요사항보고서(무상증자결정) | 2020-06-04 | Korean | |
| [기재정정]주요사항보고서(무상증자결정) | 2020-06-02 | Korean | |
| 주요사항보고서(무상증자결정) | 2020-06-01 | Korean | |
| 주권매매거래정지(무상증자) | 2020-06-01 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
15 filings
| |||||
| 9542309 | [기재정정]주요사항보고서(무상증자결정) | 2020-06-09 | Korean | ||
| 9544159 | [기재정정]주요사항보고서(무상증자결정) | 2020-06-05 | Korean | ||
| 9545497 | [기재정정]주요사항보고서(무상증자결정) | 2020-06-04 | Korean | ||
| 9546724 | [기재정정]주요사항보고서(무상증자결정) | 2020-06-02 | Korean | ||
| 9548550 | 주요사항보고서(무상증자결정) | 2020-06-01 | Korean | ||
| 9548548 | 주권매매거래정지(무상증자) | 2020-06-01 | Korean | ||
| 9548538 | 주주명부폐쇄기간또는기준일설정 | 2020-06-01 | Korean | ||
| 9547795 | 주식매수선택권부여에관한신고 | 2020-06-01 | Korean | ||
| 9547638 | [기재정정]주요사항보고서(무상증자결정) | 2020-06-01 | Korean | ||
| 9561639 | 분기보고서 (2020.03) | 2020-05-15 | Korean | ||
| 9582420 | 투자판단관련주요경영사항(항체-약물 복합체(ADC) 항암신약 후보물질 기술이전 계약 체결) | 2020-05-14 | Korean | ||
| 9585846 | 기업설명회(IR)개최 | 2020-05-12 | Korean | ||
| 9604286 | 투자판단관련주요경영사항(항체-약물 복합체(ADC) 원천기술 이전계약(라이선스) 체결) | 2020-04-14 | Korean | ||
| 10039925 | 주식매수선택권부여에관한신고 | 2020-04-01 | Korean | ||
| 10061598 | 사업보고서 (2019.12) | 2020-03-30 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
LigaChem Biosciences Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16334/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16334 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16334 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16334 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16334}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for LigaChem Biosciences Inc. (id: 16334)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.